The $100m venture financing of Xunshi Technology was the medical devices industry’s top venture financing deal as total deals worth $930m were announced globally in October 2022, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 20.5% over the previous month of $1.17bn and a drop of 53.3% when compared with the last 12-month average, which stood at $1.99bn.
Comparing venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $527.35m. At the country level, the US topped the list in terms of deal value at $527.35m.
In terms of volumes, North America emerged as the top region for medical devices industry venture financing deals globally, followed by Asia-Pacific and then Europe.
The top country in terms of venture financing deals activity in October 2022 was the US with 61 deals, followed by the China with 16 and the UK with five.
In 2022, as of October, medical devices venture financing deals worth $16.79bn were announced globally, marking a decrease of 30.8% year on year.
medical devices industry venture financing deals in October 2022: Top deals
The top five medical devices industry venture financing deals accounted for 34.5% of the overall value during October 2022.
The combined value of the top five medical devices venture financing deals stood at $321m, against the overall value of $930m recorded for the month.
The top five medical devices industry venture financing deals of October 2022 tracked by GlobalData were:
1) Chende Capital, SoftBank Vision Fund 2, Yiheng Capital Partners, Yuanyi Capital and Zhongwei Capital HoldingLimited’s $100m venture financing deal with Xunshi Technology
2) The $71m venture financing of Resolve BioSciences by Alafi CapitalLLC, EDBI, NRW.Bank, Patient Square Capital and PS Capital Partners
3) Anne Wojcicki, Cindy Crawford, Eric Schmidt, Felicis Ventures, Rande Gerber, Timothy A. Springer and Tony Fadell’s $70m venture financing deal with Prenuvo
4) The $40m venture financing of Radiomedix by Portland Investment Counsel
5) Deerfield Management Co and Foresite Capital Management’s $40m venture financing deal with Pleno